<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="37" ids="16236,44730">Ethanol</z:chebi> (<z:chebi fb="0" ids="16236">EtOH</z:chebi>) and cocaine are both self-administered into the posterior ventral tegmental area (VTA) </plain></SENT>
<SENT sid="1" pm="."><plain>Self-administration of either drug is prevented by coadministration of a <z:chebi fb="19" ids="28790">serotonin</z:chebi> (<z:chebi fb="0" ids="28790">5-HT</z:chebi>₃) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Electrophysiological studies indicated that cocaine and <z:chebi fb="0" ids="16236">EtOH</z:chebi> can act synergistically to stimulate VTA <z:chebi fb="40" ids="18243">dopamine</z:chebi> neurons </plain></SENT>
<SENT sid="3" pm="."><plain>The current experiment assessed whether cocaine and <z:chebi fb="0" ids="16236">EtOH</z:chebi> would synergistically interact to produce a reinforcing action within the posterior VTA </plain></SENT>
<SENT sid="4" pm="."><plain>Adult female Wistar rats were randomly assigned to one of 13 groups </plain></SENT>
<SENT sid="5" pm="."><plain>There were three control groups: artificial cerebrospinal fluid (aCSF), a subthreshold <z:chebi fb="0" ids="16236">EtOH</z:chebi> (100 mg%) group, and a subthreshold cocaine (25 pmol/100 nl) group </plain></SENT>
<SENT sid="6" pm="."><plain>The other groups self-administered 50 or 75 mg% <z:chebi fb="0" ids="16236">EtOH</z:chebi> containing 6.25, 12.5, or 25 pmol/100 nl cocaine or 100 mg% <z:chebi fb="0" ids="16236">EtOH</z:chebi> containing 3.12, 6.25, 12.5, or 25 pmol/100 nl cocaine </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> rats received the assigned infusate for sessions 1 through 4, aCSF alone in sessions 5 and 6, and the original infusate during session 7 </plain></SENT>
<SENT sid="8" pm="."><plain>The effects of adding a <z:chebi fb="0" ids="28790">5-HT</z:chebi>₃ receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> [tropisetron, C₁₇H₂₀N₂O₂ (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICS</z:e> 205,930) and C₁₇H₂₂N₄O.C₄H₄O₄ (LY278-584)] on coadministration of <z:chebi fb="0" ids="16236">EtOH</z:chebi> and cocaine (75 mg% + 12.5 pmol/100 nl) were determined </plain></SENT>
<SENT sid="9" pm="."><plain>Rats failed to self-administer aCSF or the subthreshold concentration of <z:chebi fb="0" ids="16236">EtOH</z:chebi> or cocaine </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> three concentrations of <z:chebi fb="0" ids="16236">EtOH</z:chebi> (50, 75, and 100 mg%) combined with cocaine (12.5 and 25 pmol/100 nl) supported self-administration </plain></SENT>
<SENT sid="11" pm="."><plain>Adding a <z:chebi fb="0" ids="28790">5HT</z:chebi>₃ receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> attenuated coadministration of <z:chebi fb="0" ids="16236">EtOH</z:chebi> + cocaine </plain></SENT>
<SENT sid="12" pm="."><plain>Overall, the data indicate that the reinforcing properties of <z:chebi fb="0" ids="16236">EtOH</z:chebi> and cocaine interacted synergistically within the posterior VTA, and these synergistic effects were mediated, at least in part, by activation of local <z:chebi fb="0" ids="28790">5-HT</z:chebi>₃ receptors </plain></SENT>
</text></document>